The knockout of HER2 inhibits the expression of the Akt–mTOR pathway and PD‐L1 gene and effectively increases the sensitivity of gastric cancer organoid tumors to anti‐PD‐1 therapy in vitro.301. The gene discussed is MTOR; the disease is gastric cancer.